Testing effectiveness (Phase 2)Study completedNCT03624010
What this trial is testing
Open-Label Rollover Study of Levosimendan in PH-HFpEF Patients
Who this might be right for
Hypertension Pulmonary Secondary Heart FailureRight Sided Heart Failure With Normal Ejection FractionHeart Failure With Normal Ejection Fraction
Tenax Therapeutics, Inc. 20